BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2008
View Archived Issues
Strong immunosuppression by natural compound improves EAE in mice
Read More
New compounds for treating cancer disclosed in recent patent literature
Read More
Allergan patent describes new therapeutic agents for glaucoma
Read More
New agents for treating neurological disorders reported in recent patents
Read More
Mechanism of AMPA receptor antagonist protection against viral encephalomyelitis explored
Read More
Topical alpha-linolenic acid demonstrates preclinical activity in dry eye
Read More
Multiple targeting yields enhanced preclinical antitumor effects in head and neck cancer
Read More
Positive interim data for Sunesis' lead product candidate in platinum-resistant ovarian cancer
Read More
Ortho Biotech modifies prescribing information for Procrit following guidance from FDA
Read More
Wyeth to conclude collaboration agreement with Curis for Hedgehog agonists in stroke
Read More
Oramed successfully completes phase Ib clinical trials of oral insulin capsule
Read More
Optimer completes enrollment in phase III clinical trial of prulifloxacin in travelers' diarrhea
Read More
DSMB recommends continuation of Opexa's phase IIb TERMS study of Tovaxin in MS
Read More
Abbott enters agreement with Genentech, Roche and OSI to develop gene test for Tarceva
Read More
Health Canada grants approval to BioMimetic Therapeutics to file DLA for GEM OS1
Read More
Monogram signs agreement with Avexa to provide HIV resistance and tropism testing
Read More
ChemGenex commences phase II omacetaxine trial in AML patients
Read More
M's Science and Eisai enter agreement for sigma receptor agonist SA-4503
Read More
European approval of desvenlafaxine in VMS will require more clinical data
Read More
FDA Advisory Committee recommends approval of sugammadex
Read More
Cerimon and Novartis Pharma enter agreement for proof-of-concept study of Simulect in uveitis
Read More
Pharmexa and Ichor enter agreement to codevelop malaria and influenza DNA vaccines
Read More
Labopharm initiates phase III clinical trial of tramadol-acetaminophen combination drug
Read More